Modified dose intensive R- CODOX-M/IVAC for HIV-associated burkitt (BL) (AMC 048) shows efficacy and tolerability, and predictive potential of IRF4/MUM1 expression

Detalles Bibliográficos
Autores principales: Noy, Ariela, Kaplan, Lawrence, Lee, Jeannette, Cesarman, Ethel, Tam, Wayne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Oral Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3330038/
http://dx.doi.org/10.1186/1750-9378-7-S1-O14
_version_ 1782229921192476672
author Noy, Ariela
Kaplan, Lawrence
Lee, Jeannette
Cesarman, Ethel
Tam, Wayne
author_facet Noy, Ariela
Kaplan, Lawrence
Lee, Jeannette
Cesarman, Ethel
Tam, Wayne
author_sort Noy, Ariela
collection PubMed
description
format Online
Article
Text
id pubmed-3330038
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33300382012-04-20 Modified dose intensive R- CODOX-M/IVAC for HIV-associated burkitt (BL) (AMC 048) shows efficacy and tolerability, and predictive potential of IRF4/MUM1 expression Noy, Ariela Kaplan, Lawrence Lee, Jeannette Cesarman, Ethel Tam, Wayne Infect Agent Cancer Oral Presentation BioMed Central 2012-04-19 /pmc/articles/PMC3330038/ http://dx.doi.org/10.1186/1750-9378-7-S1-O14 Text en Copyright ©2012 Noy et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oral Presentation
Noy, Ariela
Kaplan, Lawrence
Lee, Jeannette
Cesarman, Ethel
Tam, Wayne
Modified dose intensive R- CODOX-M/IVAC for HIV-associated burkitt (BL) (AMC 048) shows efficacy and tolerability, and predictive potential of IRF4/MUM1 expression
title Modified dose intensive R- CODOX-M/IVAC for HIV-associated burkitt (BL) (AMC 048) shows efficacy and tolerability, and predictive potential of IRF4/MUM1 expression
title_full Modified dose intensive R- CODOX-M/IVAC for HIV-associated burkitt (BL) (AMC 048) shows efficacy and tolerability, and predictive potential of IRF4/MUM1 expression
title_fullStr Modified dose intensive R- CODOX-M/IVAC for HIV-associated burkitt (BL) (AMC 048) shows efficacy and tolerability, and predictive potential of IRF4/MUM1 expression
title_full_unstemmed Modified dose intensive R- CODOX-M/IVAC for HIV-associated burkitt (BL) (AMC 048) shows efficacy and tolerability, and predictive potential of IRF4/MUM1 expression
title_short Modified dose intensive R- CODOX-M/IVAC for HIV-associated burkitt (BL) (AMC 048) shows efficacy and tolerability, and predictive potential of IRF4/MUM1 expression
title_sort modified dose intensive r- codox-m/ivac for hiv-associated burkitt (bl) (amc 048) shows efficacy and tolerability, and predictive potential of irf4/mum1 expression
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3330038/
http://dx.doi.org/10.1186/1750-9378-7-S1-O14
work_keys_str_mv AT noyariela modifieddoseintensivercodoxmivacforhivassociatedburkittblamc048showsefficacyandtolerabilityandpredictivepotentialofirf4mum1expression
AT kaplanlawrence modifieddoseintensivercodoxmivacforhivassociatedburkittblamc048showsefficacyandtolerabilityandpredictivepotentialofirf4mum1expression
AT leejeannette modifieddoseintensivercodoxmivacforhivassociatedburkittblamc048showsefficacyandtolerabilityandpredictivepotentialofirf4mum1expression
AT cesarmanethel modifieddoseintensivercodoxmivacforhivassociatedburkittblamc048showsefficacyandtolerabilityandpredictivepotentialofirf4mum1expression
AT tamwayne modifieddoseintensivercodoxmivacforhivassociatedburkittblamc048showsefficacyandtolerabilityandpredictivepotentialofirf4mum1expression

Ejemplares similares